 | • レポートコード：QYR2104Z5197 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、セロトニン症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（セロトニン拮抗薬、支持療法、胃腸除染、その他）、用途別市場規模（病院用、診療所用、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・セロトニン症候群の市場動向 ・企業の競争状況、市場シェア ・セロトニン症候群の種類別市場規模（セロトニン拮抗薬、支持療法、胃腸除染、その他） ・セロトニン症候群の用途別市場規模（病院用、診療所用、その他） ・セロトニン症候群の北米市場規模2016-2027（アメリカ、カナダ） ・セロトニン症候群のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・セロトニン症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・セロトニン症候群の中南米市場規模2016-2027（メキシコ、ブラジル） ・セロトニン症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca Plc.、Eli Lilly and Company、Forest Laboratories Inc.、GlaxoSmithKline plc.、Johnson & Johnson、Merck & Co., Inc.、Pfizer, Inc.、Sanofi S.A.、Ciron Drugs & Pharmaceuticals Pvt. Ltd.） ・結論 |
Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death.
US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global serotonin syndrome diagnosis and treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.
Market Analysis and Insights: Global Serotonin Syndrome Market
The global Serotonin Syndrome market size is projected to reach US$ 349.6 million by 2026, from US$ 318.9 million in 2019, at a CAGR of 1.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Serotonin Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Serotonin Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Serotonin Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Serotonin Syndrome market.
Global Serotonin Syndrome Scope and Market Size
Serotonin Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Serotonin Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Serotonin Antagonists
Supportive Care
Gastrointestinal Decontamination
Others
Segment by Application
Hospital Use
Clinic Use
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca Plc.
Eli Lilly and Company
Forest Laboratories Inc.
GlaxoSmithKline plc.
Johnson & Johnson
Merck & Co., Inc.
Pfizer, Inc.
Sanofi S.A.
Ciron Drugs & Pharmaceuticals Pvt. Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Serotonin Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Serotonin Antagonists
1.2.3 Supportive Care
1.2.4 Gastrointestinal Decontamination
1.2.5 Others
1.3 Market by Application
1.3.1 Global Serotonin Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Serotonin Syndrome Market Perspective (2016-2027)
2.2 Serotonin Syndrome Growth Trends by Regions
2.2.1 Serotonin Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Serotonin Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Serotonin Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Serotonin Syndrome Industry Dynamic
2.3.1 Serotonin Syndrome Market Trends
2.3.2 Serotonin Syndrome Market Drivers
2.3.3 Serotonin Syndrome Market Challenges
2.3.4 Serotonin Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Serotonin Syndrome Players by Revenue
3.1.1 Global Top Serotonin Syndrome Players by Revenue (2016-2021)
3.1.2 Global Serotonin Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Serotonin Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Serotonin Syndrome Revenue
3.4 Global Serotonin Syndrome Market Concentration Ratio
3.4.1 Global Serotonin Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Serotonin Syndrome Revenue in 2020
3.5 Serotonin Syndrome Key Players Head office and Area Served
3.6 Key Players Serotonin Syndrome Product Solution and Service
3.7 Date of Enter into Serotonin Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Serotonin Syndrome Breakdown Data by Type
4.1 Global Serotonin Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Serotonin Syndrome Forecasted Market Size by Type (2022-2027)
5 Serotonin Syndrome Breakdown Data by Application
5.1 Global Serotonin Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Serotonin Syndrome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Serotonin Syndrome Market Size (2016-2027)
6.2 North America Serotonin Syndrome Market Size by Type
6.2.1 North America Serotonin Syndrome Market Size by Type (2016-2021)
6.2.2 North America Serotonin Syndrome Market Size by Type (2022-2027)
6.2.3 North America Serotonin Syndrome Market Size by Type (2016-2027)
6.3 North America Serotonin Syndrome Market Size by Application
6.3.1 North America Serotonin Syndrome Market Size by Application (2016-2021)
6.3.2 North America Serotonin Syndrome Market Size by Application (2022-2027)
6.3.3 North America Serotonin Syndrome Market Size by Application (2016-2027)
6.4 North America Serotonin Syndrome Market Size by Country
6.4.1 North America Serotonin Syndrome Market Size by Country (2016-2021)
6.4.2 North America Serotonin Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Serotonin Syndrome Market Size (2016-2027)
7.2 Europe Serotonin Syndrome Market Size by Type
7.2.1 Europe Serotonin Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Serotonin Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Serotonin Syndrome Market Size by Type (2016-2027)
7.3 Europe Serotonin Syndrome Market Size by Application
7.3.1 Europe Serotonin Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Serotonin Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Serotonin Syndrome Market Size by Application (2016-2027)
7.4 Europe Serotonin Syndrome Market Size by Country
7.4.1 Europe Serotonin Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Serotonin Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Serotonin Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Serotonin Syndrome Market Size by Type
8.2.1 Asia-Pacific Serotonin Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Serotonin Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Serotonin Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Serotonin Syndrome Market Size by Application
8.3.1 Asia-Pacific Serotonin Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Serotonin Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Serotonin Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Serotonin Syndrome Market Size by Region
8.4.1 Asia-Pacific Serotonin Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Serotonin Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Serotonin Syndrome Market Size (2016-2027)
9.2 Latin America Serotonin Syndrome Market Size by Type
9.2.1 Latin America Serotonin Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Serotonin Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Serotonin Syndrome Market Size by Type (2016-2027)
9.3 Latin America Serotonin Syndrome Market Size by Application
9.3.1 Latin America Serotonin Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Serotonin Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Serotonin Syndrome Market Size by Application (2016-2027)
9.4 Latin America Serotonin Syndrome Market Size by Country
9.4.1 Latin America Serotonin Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Serotonin Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Serotonin Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Serotonin Syndrome Market Size by Type
10.2.1 Middle East & Africa Serotonin Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Serotonin Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Serotonin Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Serotonin Syndrome Market Size by Application
10.3.1 Middle East & Africa Serotonin Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Serotonin Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Serotonin Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Serotonin Syndrome Market Size by Country
10.4.1 Middle East & Africa Serotonin Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Serotonin Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca Plc.
11.1.1 AstraZeneca Plc. Company Details
11.1.2 AstraZeneca Plc. Business Overview
11.1.3 AstraZeneca Plc. Serotonin Syndrome Introduction
11.1.4 AstraZeneca Plc. Revenue in Serotonin Syndrome Business (2016-2021)
11.1.5 AstraZeneca Plc. Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Serotonin Syndrome Introduction
11.2.4 Eli Lilly and Company Revenue in Serotonin Syndrome Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 Forest Laboratories Inc.
11.3.1 Forest Laboratories Inc. Company Details
11.3.2 Forest Laboratories Inc. Business Overview
11.3.3 Forest Laboratories Inc. Serotonin Syndrome Introduction
11.3.4 Forest Laboratories Inc. Revenue in Serotonin Syndrome Business (2016-2021)
11.3.5 Forest Laboratories Inc. Recent Development
11.4 GlaxoSmithKline plc.
11.4.1 GlaxoSmithKline plc. Company Details
11.4.2 GlaxoSmithKline plc. Business Overview
11.4.3 GlaxoSmithKline plc. Serotonin Syndrome Introduction
11.4.4 GlaxoSmithKline plc. Revenue in Serotonin Syndrome Business (2016-2021)
11.4.5 GlaxoSmithKline plc. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Serotonin Syndrome Introduction
11.5.4 Johnson & Johnson Revenue in Serotonin Syndrome Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Serotonin Syndrome Introduction
11.6.4 Merck & Co., Inc. Revenue in Serotonin Syndrome Business (2016-2021)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Details
11.7.2 Pfizer, Inc. Business Overview
11.7.3 Pfizer, Inc. Serotonin Syndrome Introduction
11.7.4 Pfizer, Inc. Revenue in Serotonin Syndrome Business (2016-2021)
11.7.5 Pfizer, Inc. Recent Development
11.8 Sanofi S.A.
11.8.1 Sanofi S.A. Company Details
11.8.2 Sanofi S.A. Business Overview
11.8.3 Sanofi S.A. Serotonin Syndrome Introduction
11.8.4 Sanofi S.A. Revenue in Serotonin Syndrome Business (2016-2021)
11.8.5 Sanofi S.A. Recent Development
11.9 Ciron Drugs & Pharmaceuticals Pvt. Ltd.
11.9.1 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Company Details
11.9.2 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Business Overview
11.9.3 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Serotonin Syndrome Introduction
11.9.4 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Revenue in Serotonin Syndrome Business (2016-2021)
11.9.5 Ciron Drugs & Pharmaceuticals Pvt. Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Serotonin Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Serotonin Antagonists
Table 3. Key Players of Supportive Care
Table 4. Key Players of Gastrointestinal Decontamination
Table 5. Key Players of Others
Table 6. Global Serotonin Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Serotonin Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Serotonin Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Serotonin Syndrome Market Share by Regions (2016-2021)
Table 10. Global Serotonin Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Serotonin Syndrome Market Share by Regions (2022-2027)
Table 12. Serotonin Syndrome Market Trends
Table 13. Serotonin Syndrome Market Drivers
Table 14. Serotonin Syndrome Market Challenges
Table 15. Serotonin Syndrome Market Restraints
Table 16. Global Serotonin Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Serotonin Syndrome Market Share by Players (2016-2021)
Table 18. Global Top Serotonin Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Serotonin Syndrome as of 2020)
Table 19. Ranking of Global Top Serotonin Syndrome Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Serotonin Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Serotonin Syndrome Product Solution and Service
Table 23. Date of Enter into Serotonin Syndrome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Serotonin Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Serotonin Syndrome Revenue Market Share by Type (2016-2021)
Table 27. Global Serotonin Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Serotonin Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Serotonin Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Serotonin Syndrome Revenue Market Share by Application (2016-2021)
Table 31. Global Serotonin Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Serotonin Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Serotonin Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Serotonin Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Serotonin Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Serotonin Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Serotonin Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Serotonin Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Serotonin Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Serotonin Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Serotonin Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Serotonin Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Serotonin Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Serotonin Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Serotonin Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Serotonin Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Serotonin Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Serotonin Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Serotonin Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Serotonin Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Serotonin Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Serotonin Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Serotonin Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Serotonin Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Serotonin Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Serotonin Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Serotonin Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Serotonin Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Serotonin Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Serotonin Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Serotonin Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Serotonin Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Plc. Company Details
Table 64. AstraZeneca Plc. Business Overview
Table 65. AstraZeneca Plc. Serotonin Syndrome Product
Table 66. AstraZeneca Plc. Revenue in Serotonin Syndrome Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Plc. Recent Development
Table 68. Eli Lilly and Company Company Details
Table 69. Eli Lilly and Company Business Overview
Table 70. Eli Lilly and Company Serotonin Syndrome Product
Table 71. Eli Lilly and Company Revenue in Serotonin Syndrome Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly and Company Recent Development
Table 73. Forest Laboratories Inc. Company Details
Table 74. Forest Laboratories Inc. Business Overview
Table 75. Forest Laboratories Inc. Serotonin Syndrome Product
Table 76. Forest Laboratories Inc. Revenue in Serotonin Syndrome Business (2016-2021) & (US$ Million)
Table 77. Forest Laboratories Inc. Recent Development
Table 78. GlaxoSmithKline plc. Company Details
Table 79. GlaxoSmithKline plc. Business Overview
Table 80. GlaxoSmithKline plc. Serotonin Syndrome Product
Table 81. GlaxoSmithKline plc. Revenue in Serotonin Syndrome Business (2016-2021) & (US$ Million)
Table 82. GlaxoSmithKline plc. Recent Development
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Serotonin Syndrome Product
Table 86. Johnson & Johnson Revenue in Serotonin Syndrome Business (2016-2021) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Merck & Co., Inc. Company Details
Table 89. Merck & Co., Inc. Business Overview
Table 90. Merck & Co., Inc. Serotonin Syndrome Product
Table 91. Merck & Co., Inc. Revenue in Serotonin Syndrome Business (2016-2021) & (US$ Million)
Table 92. Merck & Co., Inc. Recent Development
Table 93. Pfizer, Inc. Company Details
Table 94. Pfizer, Inc. Business Overview
Table 95. Pfizer, Inc. Serotonin Syndrome Product
Table 96. Pfizer, Inc. Revenue in Serotonin Syndrome Business (2016-2021) & (US$ Million)
Table 97. Pfizer, Inc. Recent Development
Table 98. Sanofi S.A. Company Details
Table 99. Sanofi S.A. Business Overview
Table 100. Sanofi S.A. Revenue in Serotonin Syndrome Business (2016-2021) & (US$ Million)
Table 101. Sanofi S.A. Recent Development
Table 102. Ciron Drugs & Pharmaceuticals Pvt. Ltd. Company Details
Table 103. Ciron Drugs & Pharmaceuticals Pvt. Ltd. Business Overview
Table 104. Ciron Drugs & Pharmaceuticals Pvt. Ltd. Serotonin Syndrome Product
Table 105. Ciron Drugs & Pharmaceuticals Pvt. Ltd. Revenue in Serotonin Syndrome Business (2016-2021) & (US$ Million)
Table 106. Ciron Drugs & Pharmaceuticals Pvt. Ltd. Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Serotonin Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Serotonin Antagonists Features
Figure 3. Supportive Care Features
Figure 4. Gastrointestinal Decontamination Features
Figure 5. Others Features
Figure 6. Global Serotonin Syndrome Market Share by Application: 2020 VS 2027
Figure 7. Hospital Use Case Studies
Figure 8. Clinic Use Case Studies
Figure 9. Other Case Studies
Figure 10. Serotonin Syndrome Report Years Considered
Figure 11. Global Serotonin Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Serotonin Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Serotonin Syndrome Market Share by Regions: 2020 VS 2027
Figure 14. Global Serotonin Syndrome Market Share by Regions (2022-2027)
Figure 15. Global Serotonin Syndrome Market Share by Players in 2020
Figure 16. Global Top Serotonin Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Serotonin Syndrome as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Serotonin Syndrome Revenue in 2020
Figure 18. Global Serotonin Syndrome Revenue Market Share by Type (2016-2021)
Figure 19. Global Serotonin Syndrome Revenue Market Share by Type (2022-2027)
Figure 20. North America Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Serotonin Syndrome Market Share by Type (2016-2027)
Figure 22. North America Serotonin Syndrome Market Share by Application (2016-2027)
Figure 23. North America Serotonin Syndrome Market Share by Country (2016-2027)
Figure 24. United States Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Serotonin Syndrome Market Share by Type (2016-2027)
Figure 28. Europe Serotonin Syndrome Market Share by Application (2016-2027)
Figure 29. Europe Serotonin Syndrome Market Share by Country (2016-2027)
Figure 30. Germany Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Serotonin Syndrome Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Serotonin Syndrome Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Serotonin Syndrome Market Share by Region (2016-2027)
Figure 40. China Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Serotonin Syndrome Market Share by Type (2016-2027)
Figure 48. Latin America Serotonin Syndrome Market Share by Application (2016-2027)
Figure 49. Latin America Serotonin Syndrome Market Share by Country (2016-2027)
Figure 50. Mexico Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Serotonin Syndrome Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Serotonin Syndrome Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Serotonin Syndrome Market Share by Country (2016-2027)
Figure 56. Turkey Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Serotonin Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Plc. Revenue Growth Rate in Serotonin Syndrome Business (2016-2021)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Serotonin Syndrome Business (2016-2021)
Figure 61. Forest Laboratories Inc. Revenue Growth Rate in Serotonin Syndrome Business (2016-2021)
Figure 62. GlaxoSmithKline plc. Revenue Growth Rate in Serotonin Syndrome Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Serotonin Syndrome Business (2016-2021)
Figure 64. Merck & Co., Inc. Revenue Growth Rate in Serotonin Syndrome Business (2016-2021)
Figure 65. Pfizer, Inc. Revenue Growth Rate in Serotonin Syndrome Business (2016-2021)
Figure 66. Sanofi S.A. Revenue Growth Rate in Serotonin Syndrome Business (2016-2021)
Figure 67. Ciron Drugs & Pharmaceuticals Pvt. Ltd. Revenue Growth Rate in Serotonin Syndrome Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のアスペルガー症候群治療薬市場規模・現状・予測（2021年-2027年） The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence …- 世界のゾリンジャー-エリソン症候群検査市場規模・現状・予測（2021年-2027年） Zollinger-Ellison syndrome is a rare condition in which one or more tumors form in your pancreas or the upper part of your small intestine (duodenum). Market Analysis and Insights: Global Zollinger - Ellison Syndrome Testing Market The global Zollinger - Ellison Syndrome Testing market size is proj…
- 世界のバーター症候群治療薬市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% du…
- 世界のバーター症候群治療市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
- 世界の脆弱X症候群遺伝子検査市場規模・現状・予測（2021年-2027年） Fragile X Syndrome Gene Test, designed to detect the Fragile X Syndrome gene Market Analysis and Insights: Global Fragile X Syndrome Genetic Testing Market The global Fragile X Syndrome Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR o…